Research shows 98% cure rate for prostate cancer using Stereotactic Body Radiation Therapy
A five-year study shows that Stereotactic Body Radiation Therapy (SBRT) given in five sessions offers a higher cure rate for prostate cancer than more traditional approaches. Read More
Taleei wins travel award
Reza Taleei, Ph.D., a postdoctoral researcher in the Division of Medical Physics and Engineering, has been awarded a 1,500-euro stipend to attend the Proton Therapy Cooperative Group (PTCOG) annual meeting in Prague in May. Dr. Taleei will present a poster at the conference. Read More
Jiang delivers lecture at UT Medical Branch
In April, Department Vice Chair and Director of Medical Physics Steve Jiang, Ph.D., delivered the Martin Schneider Memorial Lectureship at the University of Texas Medical Branch in Galveston, Tx. The prestigious event honors that institution’s former chair of the Department of Radiology. Dr. Jiang gave a talk on “Next Generation Radiotherapy Treatment Planning”. Read More
Department makes heavy ion grant awards
The Department of Radiation Oncology at UT Southwestern Medical Center has awarded five, two-year seed grants of $100,000 apiece to Texas researchers to facilitate research related to heavy ion therapy. Read More
NASA awards funds to study effects of space radiation during Mars mission
UT Southwestern Medical Center researchers have been awarded $3.6 million in NASA funds to study how space radiation would affect the cancer risk of astronauts taking part in deep space missions to Mars. Read More
Surgery vs. SABR: "Stablemates" trial to directly compare treatment in operable cancer patients
The results of a national trial evaluating stereotactic ablative radiotherapy (SABR) in lung cancer patients too frail to receive surgery were so positive that physicians have opened a multi-institutional trial to directly compare surgery vs. SABR in operable patients. Read More
Physician discusses stereotactic combination therapy with WFAA/Ch 8
Dr. Robert Timmerman, Professor and Medical Director of Radiation Oncology, explains why treating cancer with a combination of stereotactic radiation and immunotherapy drugs is of increasing interest to researchers, in the wake of former president Jimmy Carter's cancer cure. Read More
With CPRIT grants, new approaches for pediatric cancer treatment
Investigators in the Department of Radiation Oncology were awarded close to $2.7 million in the latest round of funding from the Cancer Prevention and Research Institute of Texas (CPRIT) to study and treat childhood cancer. Read More
Researchers develop classification model for cancers caused by most frequently mutated cancer gene
UT Southwestern Medical Center researchers have developed a classification for cancers caused by KRAS, the most frequently mutated gene in cancer, that could eventually help oncologists choose more effective, customized cancer therapies. Read More
Cancer researchers first in Texas to use new prostate rectal spacer to minimize side effects of SABR radiation treatments
UT Southwestern Medical Center cancer researchers are investigating whether an injectable, biodegradable gel can reduce potential side effects from extreme high-dose radiation treatments for prostate cancer. Read More
Two physicians added to genitourinary team
Dr. Aaron Laine and Dr. Neil Desai are the newest clinical faculty members in Radiation Oncology. Read More
New physician joins Radiation Oncology
We welcome the arrival this month of David Sher, M.D., M.P.H., as Associate Professor of Radiation Oncology and leader of the department’s head and neck team. Read More
Westover featured in NCI blog
Ken Westover, M.D., Ph.D., writes about "The Enzymology of GTP-Competitive RAS Inhibitors" on the National Cancer Institute's RAS blog. Read More
Physicians pioneer the use of stereotactic body radiation for deadly kidney cancer complication
UT Southwestern Medical Center Kidney Cancer Program investigators have published what is believed to be the first reported successful use of stereotactic body radiation therapy for an often deadly complication of kidney cancer. Read more. Read More
CPRIT awards faculty $11.5 million for recruitment and research in brain and bone cancer, biology, and immunotherapy
UT Southwestern Medical Center researchers were awarded more than $7.5 million in research grants to improve diagnostic and therapeutic services and research relating to cancers of the brain, breast, throat, and bone, as well as to improve scientific understanding of cancer biology.
UTSW receives key NCI funding to plan first U.S. Center for Heavy Ion Radiation Therapy Research
The National Cancer Institute (NCI) of the National Institutes of Health awarded UT Southwestern a $1 million planning grant to establish the country’s first National Center for Heavy Ion Radiation Therapy.
Resident wins top award at AMA Research Symposium
The American Medical Association selected Stephen G. Chun, M.D., a radiation oncology resident at UT Southwestern Medical Center, for its top award recognizing research from medicine’s brightest young minds.
Stereotactic body radiation therapy plus chemotherapy improves survival among stage 4 lung cancer patients
A clinical trial that combined the two therapy regimens more than doubled survival rates for certain stage 4 lung cancer patients.
Cancer researchers identify irreversible inhibitor for KRAS gene mutation
UT Southwestern Medical Center cancer researchers have found a molecule that selectively and irreversibly interferes with the activity of a mutated cancer gene common in 30 percent of tumors.
Video game processors to improve cancer patient care
Medical physicists at UT Southwestern Medical Center are finding new ways to use the speed of video game processors to promote research that is aimed at improving patient care.
Blocking DNA repair could improve radiation therapy for brain cancer
UT Southwestern Medical Center researchers have demonstrated in both cancer cell lines and in mice that blocking critical DNA repair mechanisms could improve the effectiveness of radiation therapy for highly fatal brain tumors called glioblastomas.
Possible world's first: Physicians use CyberKnife to treat vocal cord cancer
Stephen Wiley went from being a life-long cowboy to one of the world’s first patients to have vocal cord cancer treated by the CyberKnife, a robot that destroys tumors with highly precise doses of radiation. Read More